Shopping Cart
Remove All
Your shopping cart is currently empty
Botensilimab
😃Good
Catalog No. T76933Cas No. 2408310-37-0
Alias AGEN1181, AGEN 1181
Botensilimab (AGEN 1181) is a humanized monoclonal antibody that specifically targets cytotoxic T-lymphocyte antigen 4 (CTLA-4). Botensilimab (AGEN 1181) functions as a potent activator of both innate and adaptive immune responses. Botensilimab (AGEN 1181) is under active research for its capacity to enhance antitumor immunity and modulate checkpoint pathways.
Botensilimab
Botensilimab
😃Good
Purity: 95%
Catalog No. T76933Alias AGEN1181, AGEN 1181Cas No. 2408310-37-0
Botensilimab (AGEN 1181) is a humanized monoclonal antibody that specifically targets cytotoxic T-lymphocyte antigen 4 (CTLA-4). Botensilimab (AGEN 1181) functions as a potent activator of both innate and adaptive immune responses. Botensilimab (AGEN 1181) is under active research for its capacity to enhance antitumor immunity and modulate checkpoint pathways.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $213 | - | In Stock | |
| 5 mg | $562 | - | In Stock | |
| 10 mg | $893 | - | In Stock | |
| 25 mg | $1,320 | - | In Stock | |
| 50 mg | $1,780 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:95.7% (SDS-PAGE); 97.9% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Botensilimab (AGEN 1181) is a humanized monoclonal antibody that specifically targets cytotoxic T-lymphocyte antigen 4 (CTLA-4). Botensilimab (AGEN 1181) functions as a potent activator of both innate and adaptive immune responses. Botensilimab (AGEN 1181) is under active research for its capacity to enhance antitumor immunity and modulate checkpoint pathways. |
| In vitro | The Fc region of Botensilimab has improved properties that allow for more efficient binding to Fcγ receptors on antigen-presenting cells and natural killer cells [1]. |
| Synonyms | AGEN1181, AGEN 1181 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CTLA-4/CD152 |
| Molecular Weight | 144.52 kDa |
| Cas No. | 2408310-37-0 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Botensilimab | purchase Botensilimab | Botensilimab cost | order Botensilimab | Botensilimab in vitro | Botensilimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.